Currently out of the existing stock ratings of Jessica Tassan, 35 are a HOLD (26.92%), 3 are a SELL (2.31%), 92 are a BUY (70.77%).

Jessica Tassan

Work Performance Price Targets & Ratings Chart

Analyst Jessica Tassan, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 53.22% that have a potential upside of 14.86% achieved within 100 days.

Jessica Tassan’s has documented 259 price targets and ratings displayed on 25 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CVS, CVS Health Corp at 10-Dec-2025.

Wall Street Analyst Jessica Tassan

Analyst best performing recommendations are on ACCD (ACCOLADE ).
The best stock recommendation documented was for HCAT (HEALTH CATALYST) at 9/13/2022. The price target of $11 was fulfilled within 1 day with a profit of $0.28 (2.61%) receiving and performance score of 26.12.

Average potential price target upside

of $78.69 (19.06%) on UNH (UNITEDHEALTH GROUP).
of $26.16 (9.45%) on HUM (HUMANA).
of $11.95 (19.54%) on CVS (CVS HEALTH CORP).

CANO Cano Health CMAX CareMax HCAT Health Catalyst SGFY Signify Health TRHC Tabula Rasa HealthCare CHNG Change Healthcare EVH Evolent Health OMCL Omnicell OSH Oak Street Health PHR Phreesia TDOC Teladoc ALHC Alignment Healthcare LLC PRVA Privia Health Group AMWL American Well Corp DOCS Doximity MDRX Allscripts Healthcare Solutions ACCD Accolade CVS CVS Health Corp NXGN Nextgen Healthcare PINC Premier UNH UnitedHealth Group MPLN MultiPlan CI Cigna Corp HUM Humana OSCR Oscar Health

Show more stocks

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score